Niranjan Sardesai is COO at INOVIO PHARMACEUTICALS, INC. (INO). They have made 6 open-market trades across 1 company since 2012, most recently 2018-03-10.
CIK 0001055726
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $62K since 2012, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INO | 115,601 | $114K |
Shares reported on the most recent Form 4, priced at the 2018-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INO | SELL | 2016-08-29 | 2016-08-30 | $9.30 | $405K | -1.6% | -1.7% | -24.1% |
| INO | SELL | 2016-08-29 | 2016-08-30 | $9.30 | $203K | -1.6% | -1.7% | -24.1% |
| INO | BUY | 2015-09-30 | 2015-09-30 | $5.50 | $22K | -20.0% | -0.9% | -0.9% |
| INO | BUY | 2014-08-12 | 2014-08-12 | $8.70 | $22K | -20.0% | -0.9% | -0.9% |
| INO | BUY | 2013-03-20 | 2013-03-22 | $0.53 | $13K | -20.0% | -0.9% | -0.9% |
| INO | BUY | 2012-05-16 | 2012-05-17 | $0.45 | $5K | -20.0% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.